Red Flags in Pharmacy Lien Cases: When Something Doesn't Look Right

James Wong — Founder & Pharmacist, LienScripts | March 29, 2026 | 9 min read

Not every pharmacy lien is straightforward. This guide identifies the red flags that should trigger additional scrutiny — from billing anomalies and prescribing patterns to documentation gaps and unreasonable charges.

This post is for informational purposes only and does not constitute legal advice.

A pharmacy lien red flag is any indicator in the lien documentation, billing pattern, or prescribing record that warrants additional investigation before the attorney accepts the lien amount and allocates settlement funds. Red flags do not necessarily mean fraud or error — but they signal that something requires explanation, and the attorney has an obligation to investigate before disbursing client funds.

• Red flags fall into four categories: billing anomalies, prescribing pattern issues, documentation gaps, and pricing concerns
• Identifying red flags early allows correction before settlement — identifying them at disbursement creates delays and disputes
• LienScripts generates a POGOS (Pharmacy-Organized General Occurrence Summary) report for every case, providing pharmacist-signed documentation for demand packages
• Most red flags have innocent explanations, but every one should be documented and resolved before the attorney approves the lien for payment

[!KEY] A red flag is not an accusation — it is a prompt to investigate. The attorney's obligation is to identify, investigate, and resolve every red flag before authorizing payment from client funds.

Category 1: Billing Anomalies

Fills Before the Injury Date

Any medication fill dated before the date of injury should not appear on the lien statement. This is the most straightforward billing error and usually reflects an enrollment date or system entry error rather than intentional overbilling.

What to do: Contact the lien provider, identify the specific fills, and request a corrected statement.

Duplicate Fills

Multiple fills of the same medication on the same date or within an unreasonably short interval (less than the days' supply of the prior fill) warrant investigation.

What to do: Check whether the duplicate represents a dosage change, a partial fill followed by a completion, or a billing error. Request explanation from the lien provider.

Fills After Treatment Conclusion

If the treating physician has discharged the client or the case has reached maximum medical improvement, fills occurring after that date need justification. The client may have legitimate ongoing medication needs, but they should be documented.

What to do: Verify with the treating provider whether ongoing prescriptions were authorized. If not, request removal from the lien statement.

Unusually High Fill Frequency

According to James Wong, PharmD, founder of LienScripts, "The fill frequency is one of the first things we review in our quality assurance process. A medication prescribed for 30-day supply that shows fills every 20 days is not necessarily wrong — early refills happen for legitimate reasons — but it requires explanation."

[!TIP] Compare the fill frequency against the prescribed days' supply for each medication. Any fill occurring more than 7 days before the prior fill's days' supply expires should be flagged for review.

Category 2: Prescribing Pattern Issues

Medications Without a Matching Diagnosis

Every medication on the lien should correspond to a diagnosis documented in the treating physician's records. A medication for a condition not referenced in any medical record raises the question of whether it is injury-related.

What to do: Cross-reference each medication against the treating provider's progress notes. If a medication lacks a corresponding diagnosis, request clarification.

Prescriptions from Unrelated Providers

Medications prescribed by providers not involved in the client's injury treatment may not belong on the lien. A prescription from the client's primary care physician for a chronic condition unrelated to the injury is not a lien charge.

What to do: Verify the prescribing relationship for each medication. Flag any prescriptions from providers outside the treatment team.

Rapid Escalation Without Clinical Documentation

A medication regimen that escalates rapidly — from generic NSAIDs to opioids to specialty medications — within a short timeframe should have corresponding clinical documentation supporting each escalation step.

What to do: Review the treating provider's records for progress notes documenting the clinical basis for each medication change.

Concurrent Prescriptions in the Same Class

Multiple medications in the same therapeutic class prescribed simultaneously (e.g., two different opioids, two different muscle relaxants) should have clinical justification documented.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Concurrent same-class prescriptions are not automatically inappropriate — a patient might legitimately take a long-acting and short-acting opioid simultaneously, or two different muscle relaxants for different purposes. But the clinical rationale should be documented. If it's not, that's the red flag."

Category 3: Documentation Gaps

Missing Prescriber Records

If the lien includes medications but the case file contains no records from the prescribing provider, there is a documentation gap that weakens the lien's defensibility and raises questions about the prescribing relationship.

What to do: Request records from the prescribing provider. If records cannot be obtained, discuss with the lien provider whether those medications should remain on the lien.

No Clinical Narrative

A pharmacy lien with no accompanying clinical narrative (such as a POGOS report) is a documentation red flag. The bare lien statement provides no clinical context for the medications and leaves the charges vulnerable to challenge.

What to do: Request a POGOS (Pharmacy-Organized General Occurrence Summary) report that provides clinical justification for the medication regimen.

Inconsistencies Between Pharmacy and Medical Records

If the pharmacy records show medications that are not mentioned in the medical records, or the medical records reference prescriptions that do not appear on the pharmacy lien, investigate the discrepancy.

[!KEY] The pharmacy record and the medical record should tell the same story. When they diverge, one of them is incomplete or incorrect — and the attorney's job is to determine which one and fix it before settlement.

Category 4: Pricing Concerns

No Pricing Methodology Provided

If the lien provider cannot or will not explain their pricing methodology, that is a significant red flag. Transparent providers have documented pricing frameworks and will explain them upon request.

What to do: Request the pricing methodology in writing. If the provider refuses, consider whether the lien amount should be accepted at face value.

Charges Significantly Above Comparable Cases

While every case is different, pharmacy lien charges that are dramatically higher than comparable cases with similar medications and treatment durations warrant investigation.

What to do: Compare the charges against your firm's experience with similar cases. If the charges appear significantly elevated, request an explanation and consider negotiation.

Inconsistent Pricing Within the Same Lien

If the same medication appears at different prices on different fill dates without explanation (different quantities, dosage changes, or pricing adjustments), investigate the inconsistency.

Red Flag Investigation Protocol

When you identify a red flag:

1. Document it — Note the specific red flag, the date identified, and the evidence
2. Contact the lien provider — Request an explanation in writing
3. Evaluate the response — Determine whether the explanation is satisfactory
4. Resolve or escalate — Either accept the explanation and document it, or request correction
5. Inform the client — If the red flag affects the lien amount, inform the client of the issue and resolution

How LienScripts Addresses Red Flags

The LienScripts platform includes built-in quality assurance checks that flag billing anomalies, fill frequency issues, and documentation gaps before they reach the attorney. The POGOS report provides the clinical narrative that resolves most prescribing pattern questions, and the transparent pricing methodology eliminates pricing-related red flags.

For more on pharmacy lien review, visit for attorneys.

Related Resources

• Pre-Settlement Pharmacy Lien Audit Checklist
• Audit-Proof Pharmacy Lien Documentation